Przepiorka D et al. |
Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation. |
1999 |
Bone Marrow Transplant. |
pmid:10414918
|
Varghese Z et al. |
Calcineurin inhibitors enhance low-density lipoprotein oxidation in transplant patients. |
1999 |
Kidney Int. Suppl. |
pmid:10412758
|
Muegge I et al. |
Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein. |
1999 |
J. Med. Chem. |
pmid:10411471
|
Rhew JH et al. |
Induction of fibronectin gene expression by inhibitors of protein phosphatase type 2B in normal and transformed fibroblasts. |
1999 |
Exp. Mol. Med. |
pmid:10410305
|
Hebert MF and Lam AY |
Diltiazem increases tacrolimus concentrations. |
1999 |
Ann Pharmacother |
pmid:10410178
|
Kaibori M et al. |
Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes. |
1999 |
J. Hepatol. |
pmid:10406194
|
Banerjee C et al. |
Ca2+ and calmodulin-dependent protein phosphatase from Leishmania donovani. |
1999 |
Parasitology |
pmid:10406035
|
Timmermann W et al. |
Videomicroscopic imaging of graft mucosa for monitoring immunosuppressive therapy after small intestinal transplantation in rats. |
1999 |
Transplantation |
pmid:10401762
|
Tada H et al. |
Role of diltiazem on tacrolimus pharmacokinetics in tacrolimus-induced nephrotoxic rats. |
1999 |
Pharmacol. Toxicol. |
pmid:10401724
|
Katayama Y |
[Current tendency in treatment for acute ischemic stroke]. |
1999 |
Nippon Ika Daigaku Zasshi |
pmid:10401232
|
Haas M et al. |
Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. |
1999 |
Am. J. Kidney Dis. |
pmid:10401019
|
Gold BG et al. |
Efficacy of delayed or discontinuous FK506 administrations on nerve regeneration in the rat sciatic nerve crush model: lack of evidence for a conditioning lesion-like effect. |
1999 |
Neurosci. Lett. |
pmid:10400242
|
Magee CC et al. |
Immunosuppressive agents in organ transplantation. |
1999 |
Hosp Med |
pmid:10396414
|
Kochi S et al. |
Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells. |
1999 |
Eur. J. Pharmacol. |
pmid:10395024
|
Horowitz MM et al. |
Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. |
1999 |
Biol. Blood Marrow Transplant. |
pmid:10392964
|
Hasselder AS |
The nursing management of a patient receiving Prograf as a primary immunosuppressive agent. |
1998 Apr-Jun |
EDTNA ERCA J |
pmid:10392057
|
Liang H et al. |
Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. |
1999 |
J. Biol. Chem. |
pmid:10391929
|
Gerhardt U et al. |
Blood pressure control in kidney transplant recipients: influence of immunosuppression. |
1999 |
J Auton Pharmacol |
pmid:10385269
|
Squadrito F et al. |
Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock. |
1999 |
Br. J. Pharmacol. |
pmid:10385251
|
Leung W et al. |
Long-term complete remission and immune tolerance after intensive chemotherapy for lymphoproliferative disorders complicating liver transplant. |
1999 |
Transplantation |
pmid:10385092
|